Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KP496 is a selective, dual antagonist for Thromboxane A2 receptor and Leukotriene D4 receptor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | KP496 is a selective, dual antagonist for Thromboxane A2 receptor and Leukotriene D4 receptor. |
In vivo | KP496 and prednisolone markedly reduce the rise in hydroxyl-L-proline levels in the lung, showing an inhibition ratio of approximately 74% and 63%, respectively, when compared to their own vehicle control groups. Both compounds at doses of KP496 (100 mg/head) and prednisolone (10 mg/kg) significantly decrease the infiltration of total cells, including eosinophils, monocytes/macrophages, and lymphocytes, relative to the control group. Additionally, KP496 at a lower dose (30mg/head) reduces the infiltration of these cell types, except for neutrophils, albeit not significantly. Furthermore, KP496 effectively curtails both acute (day 7) and chronic (day 21) lung inflammation, reducing lymphocyte numbers by day 7 and counts of macrophages, neutrophils, and eosinophils on days 7 and 21. |
Molecular Weight | 692.27 |
Formula | C31H34ClN3O7S3 |
CAS No. | 217799-03-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KP496 217799-03-6 Others KP 496 KP-496 inhibitor inhibit